KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Receivables - Net (2016 - 2025)

Historic Receivables - Net for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $625.0 million.

  • West Pharmaceutical Services' Receivables - Net rose 1920.66% to $625.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $625.0 million, marking a year-over-year increase of 1920.66%. This contributed to the annual value of $552.5 million for FY2024, which is 791.02% up from last year.
  • As of Q3 2025, West Pharmaceutical Services' Receivables - Net stood at $625.0 million, which was up 1920.66% from $582.4 million recorded in Q2 2025.
  • Over the past 5 years, West Pharmaceutical Services' Receivables - Net peaked at $625.0 million during Q3 2025, and registered a low of $465.7 million during Q1 2021.
  • Moreover, its 5-year median value for Receivables - Net was $513.4 million (2023), whereas its average is $518.0 million.
  • In the last 5 years, West Pharmaceutical Services' Receivables - Net soared by 4107.46% in 2021 and then crashed by 1029.19% in 2024.
  • West Pharmaceutical Services' Receivables - Net (Quarter) stood at $489.0 million in 2021, then increased by 3.76% to $507.4 million in 2022, then grew by 0.91% to $512.0 million in 2023, then grew by 7.91% to $552.5 million in 2024, then grew by 13.12% to $625.0 million in 2025.
  • Its Receivables - Net was $625.0 million in Q3 2025, compared to $582.4 million in Q2 2025 and $543.6 million in Q1 2025.